| Jul 10 |
Top Medical Stocks to Buy for Growth & Performance
|
| Jul 10 |
How to Find Strong Buy Medical Stocks Using the Zacks Rank
|
| Jul 10 |
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
|
| Jul 9 |
Is Halozyme Therapeutics (HALO) a Solid Growth Stock? 3 Reasons to Think "Yes"
|
| Jul 5 |
3 Highly Rated Biotech Stocks for Your July Buy List
|
| Jul 3 |
How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
|
| Jun 27 |
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
| Jun 25 |
Roche’s Ocrevus SC administration approved by European Commission
|
| Jun 25 |
Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
|
| Jun 24 |
Halozyme Therapeutics (NASDAQ:HALO) shareholder returns have been stellar, earning 193% in 5 years
|
